Your browser doesn't support javascript.
loading
Sodium-glucose co-transporter-2 inhibitor (SGLT2i) treatment and risk of osteomyelitis: A pharmacovigilance study of the FAERS database.
Zhao, Hui; Li, Zi-Ran; Zhang, Qian; Zhong, Ming-Kang; Yan, Ming-Ming; Qiu, Xiao-Yan.
Afiliação
  • Zhao H; Clinical Pharmacy Department, Huashan Hospital, Fudan University, Shanghai, China.
  • Li ZR; Clinical Pharmacy Department, Huashan Hospital, Fudan University, Shanghai, China.
  • Zhang Q; Clinical Pharmacy Department, Huashan Hospital, Fudan University, Shanghai, China.
  • Zhong MK; Clinical Pharmacy Department, Huashan Hospital, Fudan University, Shanghai, China.
  • Yan MM; Clinical Pharmacy Department, Huashan Hospital, Fudan University, Shanghai, China.
  • Qiu XY; Clinical Pharmacy Department, Huashan Hospital, Fudan University, Shanghai, China.
Front Pharmacol ; 14: 1110575, 2023.
Article em En | MEDLINE | ID: mdl-36865915
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article